drugset / Trial / NCT05622877

The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque

NCT05622877 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study on the prediction model of carotid unstable plaque protein and its early intervention. Protein antibody chip was used to detect the remaining biological samples, and patients with carotid artery unstable plaque with stroke risk were selected for interventional clinical trials. The selected patients were randomly divided into 3 groups, which were treated with Zhu's Wenban Formula (TCM compound granules), Qushi Formula (TCM compound granules) and placebo for 6 months, respectively. The size and number of carotid artery unstable plaques before and after 6 months were observed, and the occurrence of adverse reactions during the intervention period was observed.

Timeline

Start
2023-05-31
Primary completion
2024-01-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Qushi Formula Traditional medicine (herbal / TCM) 6 g —
Subject Zhu's Wenban Formula Traditional medicine (herbal / TCM) 6 g —

Indications